Pfizer is facing at least three class action lawsuits alleging that the company went to extraordinary, fraudulent lengths to maintain exclusivity over its multibillion dollar arthritis pain drug Celebrex and keep generic competitors off the market.
Simplifying Global Compliance
Pfizer Hit With Class Action Lawsuits Alleging Generic Celebrex Delay
Generic Line